Cell Membrane Microparticles in Blood and Blood Products: Potentially Pathogenic Agents and Diagnostic Markers

Freyssinet, 2003, Cellular microparticles: What are they bad or good for?, J. Thromb. Haemost., 1, 1655, 10.1046/j.1538-7836.2003.00309.x

Horstman, 1999, Platelet microparticles: A wide-angle perspective, Crit. Rev. Oncol. Hematol., 30, 111, 10.1016/S1040-8428(98)00044-4

Horstman, 2004, New horizons in the analysis of circulating cell-derived microparticles, Keio J. Med., 53, 210, 10.2302/kjm.53.210

Horstman, 2004, Endothelial microparticles as markers of endothelial dysfunction, Front. Biosci., 9, 1118, 10.2741/1270

Morel, 2004, Cellular microparticles: A disseminated storage pool of bioactive vascular effectors, Curr. Opin. Hematol., 11, 156, 10.1097/01.moh.0000131441.10020.87

Nomura, 2004, Platelet microparticles, Methods Mol. Biol., 272, 269

Jimenez, 2003, Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis, Thromb. Res., 109, 175, 10.1016/S0049-3848(03)00064-1

Nomura, 2001, Function and clinical significance of platelet-derived microparticles, Int. J. Hematol., 74, 397, 10.1007/BF02982082

Chargaff, 1946, The biological significance of the thromboplastic protein of blood, J. Biol. Chem., 166, 189, 10.1016/S0021-9258(17)34997-9

Wolf, 1967, The nature and significance of platelet products in human plasma, Br. J. Haematol., 13, 269, 10.1111/j.1365-2141.1967.tb08741.x

Mack, 2000, Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection, Nat. Med., 6, 769, 10.1038/77498

Jin, 2005, Distinct proteome features of plasma microparticles, Proteomics, 5, 1940, 10.1002/pmic.200401057

Hugel, 2005, Membrane microparticles: Two sides of the coin, Physiology (Bethesda), 20, 22, 10.1152/physiol.00029.2004

Owens, 1994, The role of platelet microparticles in hemostasis, Transfus. Med. Rev., 8, 37, 10.1016/S0887-7963(94)70096-1

Simak, 2002, Release of annexin V–binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin, BMC Cell Biol., 3, 1, 10.1186/1471-2121-3-11

Hamilton, 1990, Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex, J. Biol. Chem., 265, 3809, 10.1016/S0021-9258(19)39666-8

Combes, 1999, In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant, J. Clin. Invest., 104, 93, 10.1172/JCI4985

Zwaal, 1997, Pathophysiologic implications of membrane phospholipid asymmetry in blood cells, Blood, 89, 1121, 10.1182/blood.V89.4.1121

Seigneuret, 1984, ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: Relation to shape changes, Proc. Natl. Acad. Sci. U. S. A., 81, 3751, 10.1073/pnas.81.12.3751

Connor, 1992, Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. Evidence for an ATP-dependent and protein-mediated process, J. Biol. Chem., 267, 19412, 10.1016/S0021-9258(18)41791-7

Williamson, 1995, Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets, Biochemistry, 34, 10448, 10.1021/bi00033a017

Pasquet, 1998, Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen, Biochem. J., 333, 591, 10.1042/bj3330591

Simak, 2003, Ceramide mediated release of membrane microparticles from endothelial cells is controlled by caspase 1 activity and in contrast to executive apoptotic blebbing is kinase independent, Blood, 102, 805a

Nagata, 2005, DNA degradation in development and programmed cell death, Annu. Rev. Immunol., 23, 853, 10.1146/annurev.immunol.23.021704.115811

Mills, 1998, Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation, J. Cell. Biol., 140, 627, 10.1083/jcb.140.3.627

Maiese, 2000, Membrane asymmetry and DNA degradation: Functionally distinct determinants of neuronal programmed cell death, J. Neurosci. Res., 59, 568, 10.1002/(SICI)1097-4547(20000215)59:4<568::AID-JNR13>3.0.CO;2-R

Vanags, 1996, Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis, J. Biol. Chem., 271, 31075, 10.1074/jbc.271.49.31075

Chong, 2004, AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9, Exp. Cell Res., 296, 196, 10.1016/j.yexcr.2004.01.021

Pettus, 2002, Ceramide in apoptosis: An overview and current perspectives, Biochim. Biophys. Acta, 1585, 114, 10.1016/S1388-1981(02)00331-1

van Blitterswijk, 2003, Ceramide: Second messenger or modulator of membrane structure and dynamics?, Biochem. J., 369, 199, 10.1042/bj20021528

Boesen–de Cock, 1999, Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation, J. Biol. Chem., 274, 14255, 10.1074/jbc.274.20.14255

Brenner, 1998, Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases, Cell Death Differ., 5, 29, 10.1038/sj.cdd.4400307

Grullich, 2000, CD95(Fas/APO-1) signals ceramide generation independent of the effector stage of apoptosis, J. Biol. Chem., 275, 8650, 10.1074/jbc.275.12.8650

Wiedmer, 1991, Participation of protein kinases in complement C5b-9–induced shedding of platelet plasma membrane vesicles, Blood, 78, 2880, 10.1182/blood.V78.11.2880.2880

Yano, 1994, The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane, Biochem. J., 299, 303, 10.1042/bj2990303

Basse, 1994, Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: Are vesicles shed by filopod fragmentation?, Biochim. Biophys. Acta, 1190, 217, 10.1016/0005-2736(94)90077-9

Shet, 2003, Sickle blood contains tissue factor–positive microparticles derived from endothelial cells and monocytes, Blood, 102, 2678, 10.1182/blood-2003-03-0693

Simak, 2004, Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria, Br. J. Haematol., 125, 804, 10.1111/j.1365-2141.2004.04974.x

Anderson, 2002, A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains, Science, 296, 1821, 10.1126/science.1068886

Bodin, 2003, Lipid rafts are critical membrane domains in blood platelet activation processes, Biochim. Biophys. Acta, 1610, 247, 10.1016/S0005-2736(03)00022-1

Jy, 2002, Agonist-induced capping of adhesion proteins and microparticle shedding in cultures of human renal microvascular endothelial cells, Endothelium, 9, 179, 10.1080/10623320213632

Horejsi, 2005, Lipid rafts and their roles in T-cell activation, Microbes Infect., 7, 310, 10.1016/j.micinf.2004.12.004

Mallat, 1999, Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity, Circulation, 99, 348, 10.1161/01.CIR.99.3.348

Aupeix, 1997, The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection, J. Clin. Invest., 99, 1546, 10.1172/JCI119317

Bernal-Mizrachi, 2003, High levels of circulating endothelial microparticles in patients with acute coronary syndromes, Am. Heart J., 145, 962, 10.1016/S0002-8703(03)00103-0

Minagar, 2001, Elevated plasma endothelial microparticles in multiple sclerosis, Neurology, 56, 1319, 10.1212/WNL.56.10.1319

Preston, 2003, Effects of severe hypertension on endothelial and platelet microparticles, Hypertension, 41, 211, 10.1161/01.HYP.0000049760.15764.2D

Abid Hussein, 2003, Antigenic characterization of endothelial cell–derived microparticles and their detection ex vivo, J .Thromb. Haemost., 1, 2434, 10.1046/j.1538-7836.2003.00455.x

Nieuwland, 2000, Cellular origin and procoagulant properties of microparticles in meningococcal sepsis, Blood, 95, 930, 10.1182/blood.V95.3.930.003k46_930_935

Mallat, 2000, Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes, Circulation, 101, 841, 10.1161/01.CIR.101.8.841

Berckmans, 2001, Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation, Thromb. Haemost., 85, 639, 10.1055/s-0037-1615646

Jimenez, 2001, Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: Findings from brain and renal microvascular cell culture and patients with active disease, Br. J. Haematol., 112, 81, 10.1046/j.1365-2141.2001.02516.x

Simak, 2002, Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma, Transfusion, 42, 334, 10.1046/j.1537-2995.2002.00072.x

Simak, 2004, Elevated circulating endothelial microparticles in acute stroke patients: A correlation with brain lesion volume and outcome, Blood, 104, 954a, 10.1182/blood.V104.11.3504.3504

Jimenez, 2003, Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation, Br. J. Haematol., 123, 896, 10.1046/j.1365-2141.2003.04716.x

Falati, 2003, Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin, J. Exp. Med., 197, 1585, 10.1084/jem.20021868

Taylor, 2005, Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects, Br. J. Cancer., 92, 305, 10.1038/sj.bjc.6602316

Ogura, 2004, Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome, J. Trauma, 56, 823, 10.1097/01.TA.0000084517.39244.46

Sabatier, 2002, Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor–dependent procoagulant activity, Blood, 99, 3962, 10.1182/blood.V99.11.3962

Brogan, 2004, Endothelial microparticles and the diagnosis of the vasculitides, Intern. Med., 43, 1115, 10.2169/internalmedicine.43.1115

Diamant, 2002, Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus, Circulation, 106, 2442, 10.1161/01.CIR.0000036596.59665.C6

Chou, 2004, Hematopoietic cell–derived microparticle tissue factor contributes to fibrin formation during thrombus propagation, Blood, 104, 3190, 10.1182/blood-2004-03-0935

Aras, 2004, Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia, Blood, 103, 4545, 10.1182/blood-2003-03-0713

Biro, 2003, Human cell–derived microparticles promote thrombus formation in vivo in a tissue factor–dependent manner, J .Thromb. Haemost., 1, 2561, 10.1046/j.1538-7836.2003.00456.x

Satta, 1994, Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide, J. Immunol., 153, 3245, 10.4049/jimmunol.153.7.3245

Thery, 2002, Exosomes: Composition, biogenesis and function, Nat. Rev. Immunol., 2, 569, 10.1038/nri855

Gilbert, 1991, Platelet-derived microparticles express high affinity receptors for factor VIII, J. Biol. Chem., 266, 17261, 10.1016/S0021-9258(19)47368-7

Hoffman, 1992, Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: A flow cytometric study, Thromb. Haemost., 68, 74, 10.1055/s-0038-1656321

So, 2003, Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways, J .Thromb. Haemost., 1, 2510, 10.1111/j.1538-7836.2003.00462.x

Bogdanov, 2003, Alternatively spliced human tissue factor: A circulating, soluble, thrombogenic protein, Nat. Med., 9, 458, 10.1038/nm841

Butenas, 2005, Tissue factor activity in whole blood, Blood, 105, 2764, 10.1182/blood-2004-09-3567

Osterud, 1982, The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin, Scand. J. Haematol., 29, 175, 10.1111/j.1600-0609.1982.tb00580.x

Egorina, 2005, Intracellular and surface distribution of monocyte tissue factor: Application to intersubject variability, Arterioscler. Thromb. Vasc. Biol., 25, 1493, 10.1161/01.ATV.0000168413.29874.d7

Vandendries, 2004, Role of P-selectin and PSGL-1 in coagulation and thrombosis, Thromb. Haemost., 92, 459, 10.1160/TH04-05-0306

Day, 2005, Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall, Blood, 105, 192, 10.1182/blood-2004-06-2225

Nieuwland, 1997, Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant, Circulation, 96, 3534, 10.1161/01.CIR.96.10.3534

Muller, 2003, Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets, FASEB J., 17, 476, 10.1096/fj.02-0574fje

Schecter, 2000, Release of active tissue factor by human arterial smooth muscle cells, Circ. Res., 87, 126, 10.1161/01.RES.87.2.126

Brisset, 2003, Shedding of active tissue factor by aortic smooth muscle cells (SMCs) undergoing apoptosis, Thromb. Haemost., 90, 511, 10.1160/TH02-12-0291

Tans, 1991, Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles, Blood, 77, 2641, 10.1182/blood.V77.12.2641.2641

Satta, 1997, The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide, Br. J. Haematol., 96, 534, 10.1046/j.1365-2141.1997.d01-2059.x

Dahlback, 1992, Binding of anticoagulant vitamin K–dependent protein S to platelet-derived microparticles, Biochemistry, 31, 12769, 10.1021/bi00166a009

Jy, 1995, Platelet microparticles bind, activate and aggregate neutrophils in vitro, Blood Cells Mol. Dis., 21, 217, 10.1006/bcmd.1995.0025

Forlow, 2000, Leukocyte-leukocyte interactions mediated by platelet microparticles under flow, Blood, 95, 1317, 10.1182/blood.V95.4.1317.004k30_1317_1323

Barry, 1998, Modulation of monocyte-endothelial cell interactions by platelet microparticles, J. Clin. Invest., 102, 136, 10.1172/JCI2592

Barry, 1997, Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles, J. Clin. Invest., 99, 2118, 10.1172/JCI119385

Barry, 1999, Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2–dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase–dependent pathway, J. Biol. Chem., 274, 7545, 10.1074/jbc.274.11.7545

Pfister, 2004, Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery, Hypertension, 43, 428, 10.1161/01.HYP.0000110906.77479.91

Iwamoto, 1996, Platelet microparticles: A carrier of platelet-activating factor?, Biochem. Biophys. Res. Commun., 218, 940, 10.1006/bbrc.1996.0166

Watanabe, 2003, Endotoxins stimulate neutrophil adhesion followed by synthesis and release of platelet-activating factor in microparticles, J. Biol. Chem., 278, 33161, 10.1074/jbc.M305321200

Mause, 2005, Platelet microparticles: A transcellular delivery system for RANTES promoting monocyte recruitment on endothelium, Arterioscler. Thromb. Vasc. Biol., 25, 1512, 10.1161/01.ATV.0000170133.43608.37

Mesri, 1999, Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway, J. Biol. Chem., 274, 23111, 10.1074/jbc.274.33.23111

Gasser, 2004, Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis, Blood, 104, 2543, 10.1182/blood-2004-01-0361

Gasser, 2005, Microparticles released by human neutrophils adhere to erythrocytes in the presence of complement, Exp. Cell Res., 307, 381, 10.1016/j.yexcr.2005.03.011

Martin, 2004, Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression, Circulation, 109, 1653, 10.1161/01.CIR.0000124065.31211.6E

Brodsky, 2004, Endothelium-derived microparticles impair endothelial function in vitro, Am. J. Physiol. Heart Circ. Physiol., 286, H1910, 10.1152/ajpheart.01172.2003

Boulanger, 2001, Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction, Circulation, 104, 2649, 10.1161/hc4701.100516

Vanwijk, 2002, Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women, Am. J. Obstet. Gynecol., 187, 1686, 10.1067/mob.2002.127905

Kim, 2004, Platelet microparticles induce angiogenesis in vitro, Br. J. Haematol., 124, 376, 10.1046/j.1365-2141.2003.04773.x

Brill, 2005, Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization, Cardiovasc. Res., 67, 30, 10.1016/j.cardiores.2005.04.007

Taraboletti, 2002, Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle–associated components by endothelial cells, Am. J. Pathol., 160, 673, 10.1016/S0002-9440(10)64887-0

Mezentsev, 2005, Endothelial microparticles affect angiogenesis in vitro: The role of oxidative stress, Am. J. Physiol. Heart Circ. Physiol., 289, H1106, 10.1152/ajpheart.00265.2005

Janowska-Wieczorek, 2001, Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment, Blood, 98, 3143, 10.1182/blood.V98.10.3143

Janowska-Wieczorek, 2005, Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer, Int. J. Cancer, 113, 752, 10.1002/ijc.20657

Fritzsching, 2002, Release and intercellular transfer of cell surface CD81 via microparticles, J. Immunol., 169, 5531, 10.4049/jimmunol.169.10.5531

Combes, 2005, ABCA1 gene deletion protects against cerebral malaria: Potential pathogenic role of microparticles in neuropathology, Am. J. Pathol., 166, 295, 10.1016/S0002-9440(10)62253-5

Holada, 2000, Transmission of BSE by blood transfusion, Lancet, 356, 1772, 10.1016/S0140-6736(05)71968-1

Hunter, 2002, Transmission of prion diseases by blood transfusion, J. Gen. Virol., 83, 2897, 10.1099/0022-1317-83-11-2897

Brown, 1999, Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans, Transfusion, 39, 1169, 10.1046/j.1537-2995.1999.39111169.x

Fevrier, 2004, Exosomes: Endosomal-derived vesicles shipping extracellular messages, Curr. Opin. Cell Biol., 16, 415, 10.1016/j.ceb.2004.06.003

Fevrier, 2005, Exosomes: A bubble ride for prions?, Traffic, 6, 10, 10.1111/j.1600-0854.2004.00247.x

Bernal-Mizrachi, 2004, Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes, Int. J. Cardiol., 97, 439, 10.1016/j.ijcard.2003.10.029

Matsumoto, 2004, Increased level of oxidized LDL-dependent monocyte-derived microparticles in acute coronary syndrome, Thromb. Haemost., 91, 146, 10.1160/TH03-04-0247

Ferreira, 2004, Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles, Circulation, 110, 3599, 10.1161/01.CIR.0000148820.55611.6B

Inami, 2004, Correlation between platelet-derived microparticles and soluble L-selectin in patients undergoing hemodialysis, Thromb. Haemost., 92, 1452, 10.1055/s-0037-1614305

Nomura, 1995, Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus, Atherosclerosis, 116, 235, 10.1016/0021-9150(95)05551-7

Omoto, 2002, Detection of monocyte-derived microparticles in patients with type II diabetes mellitus, Diabetologia, 45, 550, 10.1007/s00125-001-0772-7

Morel, 2004, Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus, Thromb. Haemost., 91, 345, 10.1160/TH03-05-0294

Sabatier, 2002, Type 1 and type 2 diabetic patients display different patterns of cellular microparticles, Diabetes, 51, 2840, 10.2337/diabetes.51.9.2840

Kelton, 1992, Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles, Blood, 80, 2246, 10.1182/blood.V80.9.2246.2246

Hugel, 1999, Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia, Blood, 93, 3451, 10.1182/blood.V93.10.3451.410k27_3451_3456

Pihusch, 2002, Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation, Ann. Hematol., 81, 454, 10.1007/s00277-002-0494-z

Pihusch, 2002, Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation, Bone Marrow Transplant., 30, 381, 10.1038/sj.bmt.1703663

Greaves, 1999, Antiphospholipid antibodies and thrombosis, Lancet, 353, 1348, 10.1016/S0140-6736(98)10362-8

Bevers, 2004, The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin, Clin. Immunol., 112, 150, 10.1016/j.clim.2004.02.009

Dignat-George, 2004, Endothelial microparticles: A potential contribution to the thrombotic complications of the antiphospholipid syndrome, Thromb. Haemost., 91, 667, 10.1160/TH03-07-0487

Nagahama, 2003, Significance of anti-oxidized LDL antibody and monocyte-derived microparticles in anti-phospholipid antibody syndrome, Autoimmunity, 36, 125, 10.1080/0891693031000079257

Ambrozic, 2005, Budding, vesiculation and permeabilization of phospholipid membranes—evidence for a feasible physiologic role of beta2-glycoprotein I and pathogenic actions of anti–beta2-glycoprotein I antibodies, Biochim. Biophys. Acta, 1740, 38, 10.1016/j.bbadis.2005.02.009

Kim, 2003, Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: Possible role of a metastasis predictor, Eur J Cancer, 39, 184, 10.1016/S0959-8049(02)00596-8

Kanazawa, 2003, Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer, Lung Cancer, 39, 145, 10.1016/S0169-5002(02)00441-5

Joop, 2001, Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms, Thromb. Haemost., 85, 810, 10.1055/s-0037-1615753

Combes, 2004, Circulating endothelial microparticles in Malawian children with severe falciparum malaria complicated with coma, JAMA, 291, 2542, 10.1001/jama.291.21.2542-b

Laude, 2001, Circulating procoagulant microparticles in women with unexplained pregnancy loss: A new insight, Thromb. Haemost., 85, 18, 10.1055/s-0037-1612657

Bretelle, 2003, Circulating microparticles: A marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction, Thromb. Haemost., 89, 486, 10.1055/s-0037-1613378

VanWijk, 2002, Microparticle subpopulations are increased in preeclampsia: Possible involvement in vascular dysfunction?, Am. J. Obstet. Gynecol., 187, 450, 10.1067/mob.2002.124279

Gonzalez-Quintero, 2003, Elevated plasma endothelial microparticles in preeclampsia, Am. J. Obstet. Gynecol., 189, 589, 10.1067/S0002-9378(03)00469-1

Gonzalez-Quintero, 2004, Elevated plasma endothelial microparticles: Preeclampsia versus gestational hypertension, Am. J. Obstet. Gynecol., 191, 1418, 10.1016/j.ajog.2004.06.044

Jimenez, 2005, Elevated endothelial microparticle–monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes, Mult. Scler., 11, 310, 10.1191/1352458505ms1184oa

Lee, 1993, Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias, Thromb. Res., 72, 295, 10.1016/0049-3848(93)90138-E

Knijff-Dutmer, 2002, Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis, Arthritis Rheum., 46, 1498, 10.1002/art.10312

George, 1986, Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate, Blood, 68, 307, 10.1182/blood.V68.1.307.307

McGill, 1987, Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits, J. Lab. Clin. Med., 109, 127

Solberg, 1987, Platelet storage lesion: Formation of platelet fragments with platelet factor 3 activity, Thromb. Res., 48, 559, 10.1016/0049-3848(87)90387-2

Divers, 1995, Quantitation of CD62, soluble CD62, and lysosome-associated membrane proteins 1 and 2 for evaluation of the quality of stored platelet concentrates, Transfusion, 35, 292, 10.1046/j.1537-2995.1995.35495216076.x

Wang, 1999, Flow cytometric analysis of platelet function in stored platelet concentrates, Transfus. Sci., 20, 129, 10.1016/S0955-3886(99)00022-3

Devine, 1999, Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems, Transfusion, 39, 724, 10.1046/j.1537-2995.1999.39070724.x

George, 1988, Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates, Transfusion, 28, 123, 10.1046/j.1537-2995.1988.28288179014.x

Gemmell, 2000, Flow cytometric evaluation of material-induced platelet and complement activation, J. Biomater. Sci. Polym. Ed., 11, 1197, 10.1163/156856200744273

Bode, 1991, Vesiculation of platelets during in vitro aging, Blood, 77, 887, 10.1182/blood.V77.4.887.887

Bode, 1994, Effect of cold storage on platelet glycoprotein Ib and vesiculation, Transfusion, 34, 690, 10.1046/j.1537-2995.1994.34894353465.x

Gelderman, 2004, High counts of potentially pathogenic cell membrane microparticles in apheresis platelets, Blood, 104, 988a, 10.1182/blood.V104.11.3635.3635

Kleinman, 2003, Risks associated with transfusion of cellular blood components in Canada, Transfus. Med. Rev., 17, 120, 10.1053/tmrv.2003.50009

Vincent, 2002, Anemia and blood transfusion in critically ill patients, JAMA, 288, 1499, 10.1001/jama.288.12.1499

Rao, 2004, Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes, JAMA, 292, 1555, 10.1001/jama.292.13.1555